{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-043040","form_type":"8-K","ticker":"VRCA","cik":"0001660334","company_name":"Verrica Pharmaceuticals Inc.","filed_at":"2023-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.045478+00:00","generated_at":"2026-06-19T07:03:55.865550+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Verrica prices $32.5M underwritten offering of common stock and pre-funded warrants","bullets":["750,000 shares at $6.75 and 4,064,814 pre-funded warrants at $6.7499 per share.","Gross proceeds expected ~$32.5M before underwriting discounts and expenses.","Jefferies LLC acting as sole book-runner; closing expected Feb 23, 2023.","Offering substantially led by one healthcare dedicated fund.","Shelf registration statement (333-268229) effective Dec 19, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-043040","json":"https://secwatch.observer/filing/0001193125-23-043040.json","markdown":"https://secwatch.observer/filing/0001193125-23-043040.md","text":"https://secwatch.observer/filing/0001193125-23-043040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1660334/000119312523043040/0001193125-23-043040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1660334/000119312523043040/d464394d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T07:03:55.865550+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a156bab563daf35933a86ec9a746dc7dfdec2434","claim":"Verrica Pharmaceuticals Inc. entered into Underwriting Agreement with Jefferies LLC valued at approximately $32.5 million (effective 2023-02-21).","evidence_excerpt":"On February 21, 2023, Verrica Pharmaceuticals Inc. (the “C ompan y’) entered into an underwriting agreement (“ Underwriting Agreement ”) with Jefferies LLC (the “ Underwriter ”), to issue and sell 750,000 shares (the “ Shares ”) of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”) at a price of $6.75 per share and, in lieu of Common Stock, certain investors were issued pre-funded warrants to purchase an aggregate of 4,064,814 shares of Common Stock at a price of $6.7499 (the “ Pre-Funded Warrants ”), which represents the per share price for the Shares less the $0.0001 per share exercise price for each Pre-Funded Warrant (the “ Offering ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312523043040/0001193125-23-043040-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Jefferies LLC"},{"label":"Value","value":"approximately $32.5 million"},{"label":"Effective","value":"2023-02-21"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}